Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
11 Patents
#29 in Alameda, CA
#6,545 in California
#27,540 in US
#51,831 in the World
Scribe Therapeutics Inc.
Forward Citations = 30
20 inventors:
Alameda, CA, United States of America
Scribe Therapeutics Inc.
Calculating rank
Trademarks = 2
Forward Citations = 30
Loading Chart...
Loading Chart...
20 inventors (with patents filed for the assignee):
Benjamin Oakes (11 out of 11 patents)
Sarah Denny (11 out of 11 patents)
Sean Higgins (11 out of 11 patents)
4. Brett T Staahl (8 out of 8 patents)
5. Isabel Colin (8 out of 8 patents)
6. Hannah Spinner (6 out of 6 patents)
7. Maroof Adil (6 out of 6 patents)
8. Kian Taylor (5 out of 5 patents)
9. Katherine Baney (5 out of 5 patents)
10. Jason Fernandes (4 out of 4 patents)
11. Cole Urnes (3 out of 3 patents)
12. Suraj Makhija (3 out of 3 patents)
13. Gayathri Vijayakumar (3 out of 3 patents)
14. Angus Sidore (3 out of 3 patents)
15. Emeric Jean Marius Charles (3 out of 3 patents)
11 patents:
Company Overview
Scribe Therapeutics Inc. is a biotechnology company based in Alameda, California, specializing in the development of gene editing technologies. The organization focuses on harnessing the potential of CRISPR-based systems to create transformative therapies for genetic disorders. Scribe's innovative approach aims to enhance precision and efficiency in gene editing, positioning it at the forefront of advancements in genetic medicine. The company is committed to addressing unmet medical needs through its cutting-edge research and development efforts.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Scribe Therapeutics Inc.. Retrieved from https://idiyas.com/company/scribe-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]